Quality of adverse event reporting in clinicals trials of COVID-19 drugs : a systematic review

Study identification

• EU PAS number:
  EUPAS45959
• Study ID:
  46849
• Official title and acronym:
  Quality of adverse event reporting in clinicals trials of COVID-19 drugs : a systematic review
• DARWIN EU® study:
  No
• Study countries:
  France
• Study status:
  Planned

Research institutions and networks

Institutions

Toulouse University Hospital

Study timelines

Date when funding contract was signed

Planned: 04/01/2022

Study start date

Planned: 18/04/2022

Date of final study report

Planned: 06/06/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

National Research Agency (NRA)

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable